Testosterone Petition From Public Citizen Eyes Industry Bias In Risk Findings
This article was originally published in The Pink Sheet Daily
Executive Summary
Seeking immediate relabeling of the products, advocacy group notes a meta-analysis found different CV risk depending on who funded the studies analyzed.